Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O'Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

Cancer Research Institute is a pioneer in using immunotherapy to treat cancer. This week’s guest, Jill O’Donnell-Tormey, Ph.D., CEO and Director of Scientific Affairs, discusses the future of oncology research, the upcoming CRI Awards Gala, what it’s like working alongside a Nobel Prize winner, and her love of baking.